Nine projects awarded SBRI Healthcare Competition for Urgent & Emergency Care in England

In March 2025, Small Business Research Initiative (SBRI) Healthcare announced innovations awarded through Competition 26 Phase 3 for Urgent & Emergency Care, launched in July 2024. 

SBRI Healthcare is funded by the NHS Accelerated Access Collaborative and supported by the Health Innovation Network (HIN). SBRI Healthcare is committed to assisting the NHS in delivering the objectives of the NHS Long Term Plan.

Phase 3 funding is focused on late-stage innovations with the aim to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to make purchasing or other recommendations and decisions. 

A total of £3.9 million was allocated for the development of nine innovations that help address patient needs in Urgent & Emergency Care. 

Eight of nine awarded projects concerned e-Health. Some examples are provided below:

• Radiobotics - awarded £491,712 - Real-world evaluation to assess the clinical and health economic impact of the RBfracture software within the NHS. RBfracture™ is a CE-marked, AI-powered detection and diagnosis software device designed to support emergency and radiology staff with the detection of trauma-related problems, including fractures and joint dislocations;
• Luscii Healthtech B.V - awarded £211,333 - Scaling Acute Virtual Wards: an evidenced-based NHS blueprint. Luscii’s acute virtual ward leverages remote monitoring technology to support patients at home, reducing hospital admissions and improving care efficiency. The project aims to evaluate the ward’s health, economic, and environmental impacts, addressing health inequalities whilst developing a scalable blueprint for NHS-wide adoption of acute virtual care.

One of the nine awarded projects concerned in-vitro diagnostics:

• University of Liverpool - MeMed - awarded £476,574 - PRe-Implementation Evaluation of Fidelity and Adherence of MeMed BV rapid test in febrile Children presenting to the Emergency Department (PREFACE). MeMed BV® is an innovative rapid blood test that distinguishes bacterial from viral infections in 15 minutes based on the host-immune response. The project evaluates its adoption in NHS Emergency Departments to optimize use, reduce inappropriate antibiotic prescriptions, and ensure timely bacterial infection treatment, enhancing patient care and safety.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.